Optimizing Large Molecules & Fusion Proteins for Improved Efficacy & Reduced Liabilities with Structural Insight

• Leveraging structural insights to engineer large molecules and fusion proteins with enhanced potency and selectivity
• Applying structure-guided approaches to minimize liabilities such as immunogenicity, instability, or off-target effects
• Exploring strategies to optimize molecular architecture for improved developability, safety, and therapeutic efficacy

Speakers:

Joseph Batchelor

Head of Structural Biology for US Biologics Research

Sanofi